Marked improvement of anti-N-methyl-D-aspartate receptor encephalitis by large-dose methylprednisolone and plasmapheresis therapy combined with 18F-fluorodeoxyglucose positron emission tomography imaging: A case report

Experimental and Therapeutic Medicine

Volumn 8, Issue 4, 2014, Pages 1167-1169

  Chen, Bo ^a   Wang, Yiqi ^a   Geng, Yu ^a   Huang, Yuehong ^a   Guo, Shunyuan ^a   Mao, Xiawa ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Anti N methyl D aspartate receptor encephalitis; Plasmapheresis

Indexed keywords

ACICLOVIR; FLUORODEOXYGLUCOSE F 18; METHYLPREDNISOLONE;

ADULT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; FOLLOW UP; HUMAN; IMMUNOTHERAPY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY;

EID: 84906486778     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1849     Document Type: Article

References (13)

1. Dalmau J, Tüzün E, Wu HY, et al: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61: 25-36, 2007.
2. Graus F and Dalmau J: Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol 20: 732-737, 2007.
3. Irani SR, Bera K, Waters P, et al: N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133: 1655-1667, 2010.
4. Vincent A and Bien CG: Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults. Lancet Neurol 7: 1074-1075, 2008.
5. Florance NR, Davis RL, Lam C, et al: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neuro1 66: l1-18, 2009.
6. Leypoldt F, Buchert R, Kleiter I, et al: Fluorodeoxyglucose positron emission tomography in anti-N-methyl-D-aspartate receptor encephalitis: distinct pattern of disease. J Neurol Neurosurg Psychiatry 83: 681-686, 2012.
7. Greiner H, Leach JL, Lee KH and Krueger DA: Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure 20: 266-270, 2011.
8. Maqbool M, Oleske DA, Huq AH, Salman BA, Khodabakhsh K and Chugani HT: Novel FDG-PET findings in anti-NMDA receptor encephalitis: a case based report. J Child Neurol 26: 1325-1328, 2011.
9. Pillai SC, Gill D, Webster R, Howman-Giles R and Dale RC: Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol 43: 217-220, 2010.
10. Baumgartner A, Rauer S, Mader I and Meyer PT: Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 260: 2744-2753, 2013.
11. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR and Balice-Gordon R: Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neuro1 10: 63-74, 2011.
12. Titulaer MJ, McCracken L, Gabilondo I, et al: Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12: 157-165, 2013.
13. Pham HP, Daniel-Johnson JA, Stotler BA, Stephens H and Schwartz J: Therapeutic plasma exchange for the treatment of anti-NMDA receptor encephalitis. J Clin Apher 26: 320-325, 2011.